Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5

Eva J. Helmerhorst, Caterina Venuleo, Dominique Sanglard, Frank G. Oppenheim
Eva J. Helmerhorst
1Department of Periodontology and Oral Biology, Goldman School of Dental Medicine, Boston University, 700 Albany Street, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: helmer@bu.edu
Caterina Venuleo
1Department of Periodontology and Oral Biology, Goldman School of Dental Medicine, Boston University, 700 Albany Street, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Sanglard
2Institute of Microbiology, University Hospital Lausanne (CHUV), Rue de Bugnon 48, CH-1011 Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank G. Oppenheim
1Department of Periodontology and Oral Biology, Goldman School of Dental Medicine, Boston University, 700 Albany Street, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.50.3.1100-1103.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Histatin 5, a human salivary protein with broad-spectrum antifungal activity, is remarkably ineffective against Candida glabrata. Fluconazole resistance in this fungus is due in most cases to upregulation of CgCDR efflux pumps. We investigated whether the distinct resistance of C. glabrata to histatin 5 is related to similar mechanisms.

In the past decade, Candida glabrata has emerged as the second most common fungal pathogen in opportunistic fungal infections in humans. This increase is likely related to the widespread use of the antimycotic drug fluconazole, to which C. glabrata is inherently less sensitive than C. albicans, C. parapsilosis, and C. tropicalis (18). Resistance to azoles has been associated with the upregulation of the genes CgCDR1 and CgCDR2 (also designated PDH1) which encode proteins belonging to the ATP binding cassette family of multidrug resistance membrane-associated efflux pumps (1, 2, 12, 19, 20, 23). Other reported mechanisms of azole resistance in C. glabrata which may actually be related to CDR upregulation involve the generation or selection of respiratory-deficient petite mutants (3, 4). In the quest to develop new antimycotics with possibly different cellular targets, histatins, a group of salivary cationic proteins, have received special attention (5, 8, 16, 17, 21). While histatins are highly effective against diverse classes of fungi, they are significantly less effective against C. glabrata (9, 24). Furthermore, other, structurally unrelated, cationic antifungal peptides, belonging to the magainin and defensin family, also show a selectively reduced activity against this fungus (6, 9, 11). The cellular basis for the apparent insensitivity of C. glabrata to various antifungal agents as different as azoles and cationic antifungal proteins is as yet unknown. In the current study we evaluated the role of petite mutation, fermentation, and the activity of the efflux pumps CgCDR1 and CgCDR2 in the resistance of C. glabrata to histatin 5.

C. albicans (ATCC 10231) and C. glabrata (ATCC 90030) were cultured in 1:10 diluted Sabouraud dextrose broth (SDB; Difco, Becton Dickinson, Franklin Lakes, NJ) (9) and containing either 0, 56, 112, or 225 μg/ml of histatin 5. Assessment of the optical density at 620 nm (OD620) after 48 h of incubation at 30°C showed that C. glabrata was able to grow even in the presence of the highest concentration of histatin 5, while the growth of C. albicans was inhibited by all three histatin concentrations (Fig. 1).

Since C. glabrata resistance to fluconazole in some cases is explained by induction or selection of petite mutants (3, 4) and petite mutation in C. albicans is known to abolish sensitivity to histatin 5 (7), the respiratory competence of C. glabrata cells grown in the presence of histatin 5 was evaluated. Two experimental approaches were followed. First, 10-μl aliquots of cells grown for 48 h in the presence of the indicated three concentrations of histatin 5 were plated on glucose- or glycerol-limited agar (7), the latter strictly supporting cellular respiration. Second, since the C. glabrata petite phenotype may be a transient cellular characteristic caused by mitochondria that switch between states of respiratory competence and incompetence (12), we also measured directly the respiration of C. glabrata cells in the histatin 5-containing cell cultures. Plated C. albicans cell suspensions containing histatin 5 did not grow on agar (Fig. 2). In contrast, the histatin 5-grown C. glabrata cells grew well on glucose- and glycerol-limited agar, the latter indicating that the presence of histatin 5 during growth in diluted SDB broth had not induced “petite” characteristics. In addition, respiratory measurements using a biological oxygen monitor (Yellow Springs Instruments, Yellow Springs, Ohio) (7) of cells grown in the presence of 56, 112, or 225 μg/ml of histatin 5 indicated that the oxygen consumption of these cells in their respective supernatants was certainly not lower than that from cells that had been cultured in the absence of histatin 5 (10.6, 10.6, 10.2, and 9.0 nmol O2/min/OD620, respectively).

In previous studies it was demonstrated that cellular respiration is important in C. albicans sensitivity to histatin 5 (8). It was hypothesized that C. glabrata might escape histatin 5 activity by utilizing fermentative pathways, since theoretically dextrose (glucose) can either be fermented or assimilated. Furthermore, C. glabrata, but not C. albicans, is a Crabtree-positive fungus (22), and its respiration may be negatively affected by certain levels of glucose (15). To exclude the possibility of substrate fermentation by C. glabrata, growth inhibition assays were also conducted in broth containing only glycerol as the carbon source. C. glabrata was insensitive in either glycerol- or glucose-limited broth, exhibiting 50% inhibitory concentrations (IC50s) higher than 225 μg/ml (Fig. 3). This result shows that the resistance of this fungus to histatin 5 is not explained by mitochondrial dysfunction or lack of respiration. In contrast, C. albicans was sensitive to histatin 5 in glycerol- and glucose-containing broths, exhibiting IC50s of 13.8 ± 4.8 and 21.2 ± 2.5 μg/ml, respectively. The sensitivity of C. albicans in glucose broth is consistent with the fact that respiration of C. albicans is not suppressed by glucose (10).

Previous studies have shown that the site-directed mutation in C. glabrata of CgCDR1, CgCDR2, or both affects sensitivity to fluconazole, in particular when both genes were disrupted simultaneously (20). Using the standardized antifungal susceptibility protocol M27-A2 of the National Committee for Clinical Laboratory Standards (NCCLS) (14), we confirmed published results (20) that strains in which either CgCDR1 or both CgCDR genes were abolished showed a marked increased sensitivity to fluconazole (Table 1). Since the intracellular accumulation of histatins is required for their activity toward C. albicans (8, 13, 25), it was hypothesized that C. glabrata resistance could be related to the fact that histatin 5 fails to accumulate intracellularly as a result of the activity of efflux pumps. While it is unknown whether histatin 5 could be transported by the CgCDR1 and CgCDR2 pumps that are so effective in exporting fluconazole, it was assessed whether the mutants lacking one or both of these genes would show an increased sensitivity to histatin 5. Growth inhibition assays with histatin 5 were conducted in diluted SDB (9), since salts in RPMI medium interfere with histatin activity (9). As indicated in Table 1, the efficacy of fluconazole in RPMI medium and in diluted SDB was in most cases comparable, allowing the comparison of C. glabrata sensitivities to fluconazole and histatin 5 in diluted SDB. The results indicated that while the various C. glabrata mutants showed differential sensitivities to fluconazole, all C. glabrata strains were resistant to histatin 5 growth inhibition (IC50 > 225 μg/ml). Notably, the observed histatin 5 resistance was relative to the histatin 5 sensitivity of C. albicans, which displayed IC50 values of 9.5 ± 0.5 μg/ml. In killing assays conducted in 5 mM potassium phosphate buffer, pH 7.0 (9), similar results of C. glabrata resistance were obtained, except that the ura3 C. glabrata strain (DSY 1029) was somewhat sensitive (Table 1). These results combined indicated that C. glabrata resistance to histatin 5 is independent of mutations in CgCDR1 or CgCDR2.

The data obtained here and in our previous study (9) reveal a seemingly fundamental and widespread resistance of C. glabrata to histatin 5. While the resistance of C. glabrata to fluconazole is known to occur in cells exhibiting petite mutations and/or overexpressing specific efflux pumps, the resistance to histatin 5 is not related to either of these two mechanisms. The absence of a correlation between the responses to fluconazole and histatin 5 of the various C. glabrata mutants evaluated suggests that the cellular characteristics providing resistance against azoles and cationic antifungal proteins in this fungus are not identical.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Assessment of growth (OD620) after 48 h of incubation of C. albicans and C. glabrata in diluted SDB containing three concentrations of histatin 5. Represented are the average values and standard errors of two independent experiments, each performed in duplicate.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Determination of the viability and respiratory competence of aliquots of histatin-grown C. albicans and C. glabrata cell suspensions plated on glycerol or glucose-limited agar (7).

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Fungistatic activity of serially diluted histatin 5 toward C. albicans and three C. glabrata strains in diluted glycerol-limited broth (A), containing (per liter) 1 g peptone, 0.5 g yeast extract, 0.5 g glucose, and 0.5 g glycerol, and in glucose-limited broth (B), containing (per liter) 1 g peptone, 0.5 g yeast extract, 0.5 g glucose, and 0.5 g glycerol. Broth microdilution experiments were conducted as described previously (9). Graphs represent the averages of an experiment performed in duplicate and are representative of four independent experiments each performed in duplicate.

View this table:
  • View inline
  • View popup
TABLE 1.

Comparison of fluconazole and histatin 5 sensitivity of CgCDR1 and CgCDR2 mutants of C. glabrataa

ACKNOWLEDGMENTS

We thank Nerline Grand-Pierre and Ana S. Fraga for technical assistance.

This study is supported by NIH/NIDCR grants DE05672, DE07652, and DE14950.

FOOTNOTES

    • Received 13 September 2005.
    • Returned for modification 10 October 2005.
    • Accepted 4 January 2006.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Bennett, J. E., K. Izumikawa, and K. A. Marr. 2004. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother.48:1773-1777.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Borst, A., M. T. Raimer, D. W. Warnock, C. J. Morisson, and B. A. Arthington-Skaggs. 2005. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob. Agents Chemother.49:783-787.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Brun, S., C. Aubry, O. Lima, R. Filmon, T. Bergès, D. Chabasse, and J. P. Bouchara. 2003. Relationship between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother.47:847-853.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Defontaine, A., J. P. Bouchara, P. Declerk, C. Planchenault, D. Chabasse, and J. N. Hallet. 1999. In vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J. Med. Microbiol.48:663-670.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Edgerton, M., and S. E. Koshlukova. 2000. Salivary histatin 5 and its similarities to the other antimicrobial proteins in human saliva. Adv. Dent. Res.14:16-21.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Feng, Z., B. Jiang, J. Chandra, M. Ghannoum, S. Nelson, and A. Weinberg. 2005. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J. Dent. Res.84:445-450.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Gyurko, C., U. Lendenmann, R. F. Troxler, and F. G. Oppenheim. 2000. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Antimicrob. Agents Chemother.44:348-354.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Helmerhorst, E. J., and F. G. Oppenheim. 2004. The antifungal mechanisms of antimicrobial proteins, p. 245-277. In R. E. W. Hancock and D. Devine (ed.), Mammalian antimicrobial proteins, 1st ed. Cambridge University Press, Cambridge, United Kingdom.
  9. 9.↵
    Helmerhorst, E. J., C. Venuleo, A. Beri, and F. G. Oppenheim. 2005. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast22:705-714.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Helmerhorst, E. J., M. Stan, M. P. Murphy, F. Sherman, and F. G. Oppenheim. 2005. The concomitant expression and availability of conventional and alternative, cyanide-insensitive, respiratory pathways in Candida albicans. Mitochondrion5:200-211.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Joly, S., C. Maze, P. B. McCray Juniorperiod, and J. M. Guthmiller. 2004. Human β-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol.42:1024-1029.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Kaur, R., I. Castano, and B. P. Cormack. 2004. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob. Agents Chemother.48:1600-1613.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Koshlukova, S. E., M. W. Araujo, D. Baev, and M. Edgerton. 2000. Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect. Immun.68:6848-6856.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  15. 15.↵
    Niimi, M., A. Kamiyama, and M. Tokunaga. 1988. Respiration of medically important Candida species and Saccharomyces cerevisiae in relation to glucose effect. J. Med. Vet. Mycol.26:195-198.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Oppenheim, F. G., T. Xu, F. M. McMillian, S. M. Levitz, R. D. Diamond, G. D. Offner, and R. F. Troxler. 1988. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J. Biol. Chem.263:7472-7477.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Oppenheim, F. G. 1989. Salivary histidine-rich proteins, p. 151-160. In J. O. Tenovuo (ed.), Human saliva: clinical chemistry and microbiology. CRC Press, Boca Raton, Fla.
  18. 18.↵
    Pfaller, M. A., S. A. Messer, R. J. Hollis, R. N. Jones, and D. J. Diekema. 2002. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob. Agents Chemother.46:1723-1727.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother.43:2753-2765.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Sanglard, D., F. Ischer, and J. Bille. 2001. Role of ATP-binding cassette transporter genes in high frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother.45:1174-1183.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Tsai, H., and L. A. Bobek. 1998. Human salivary histatins: promising anti-fungal therapeutic agents. Crit. Rev. Oral Biol. Med.9:480-497.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Van Urk, H., W. S. Leopold Voll, W. A. Scheffers, and J. P. van Dijken. 1990. Transient-state analysis of metabolic fluxes in Crabtree-positive and Crabtree-negative yeasts. Appl. Environ. Microbiol.56:281-287.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Vermitsky, J.-P., and T. D. Edlind. 2004. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother.48:3773-3781.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Wei, G. X., and L. A. Bobek. 2004. In vitro synergistic antifungal effect of MUC7 12-mer with histatin 5 12-mer or miconazole. J. Antimicrob. Chemother.53:750-758.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    Xu, Y., I. Ambudkar, H. Yamagishi, W. Swaim, T. J. Walsh, and B. C. O'Connell. 1999. Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization. Antimicrob. Agents Chemother.43:2256-2262.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5
Eva J. Helmerhorst, Caterina Venuleo, Dominique Sanglard, Frank G. Oppenheim
Antimicrobial Agents and Chemotherapy Feb 2006, 50 (3) 1100-1103; DOI: 10.1128/AAC.50.3.1100-1103.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5
Eva J. Helmerhorst, Caterina Venuleo, Dominique Sanglard, Frank G. Oppenheim
Antimicrobial Agents and Chemotherapy Feb 2006, 50 (3) 1100-1103; DOI: 10.1128/AAC.50.3.1100-1103.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antifungal agents
Candida glabrata
Drug Resistance, Fungal
Genes, Fungal
Salivary Proteins and Peptides

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596